Regulation FD Disclosure Form 8 K

Item 7.01 Regulation FD Disclosure.

On January 6, 2025, the Society for Maternal Fetal Medicine ("SMFM") published an abstract (available at onlinelibrary.wiley.com/doi/epdf/10.1002/pmf2.12035) reporting topline results for the Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs ("PRIME") study. PRIME study results are scheduled to be presented in greater detail at the SMFM 2025 Pregnancy MeetingTM on January 31, 2025 (smfm2025.eventscribe.net/), and the Company will host a conference call and live audio webcast on February 6, 2025, at 12 p.m. ET to further discuss these results. Details of this conference call will be provided closer to the date.

The information contained in Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or into any filing or other document pursuant to the Exchange Act, except to the extent required by applicable law or regulation.